The Medicare GLP-1 Bridge Program is still ongoing. Launched July 1, 2026, the temporary program provides eligible Medicare beneficiaries access to certain GLP-1 medications for weight management for $50 per month, including Foundayo®, Wegovy® (injection and tablets), and Zepbound® (KwikPen®). The program is scheduled to continue through December 31, 2027. Medicare has established eligibility criteria. To be eligible, beneficiaries must be enrolled in a Medicare prescription

The summer edition of our newsletter is now available! Check it out to learn more about Medicare-covered preventive services for beneficiaries, medical equipment fraud in practice, our latest blog updates, continuing education resources, and more!

The U.S. Food and Drug Administration (FDA) approved mFlusiva, an mRNA influenza vaccine developed by Moderna, on August 5. This first mRNA-based influenza vaccine is approved for use in individuals aged 50 years and older for the prevention of influenza disease caused by influenza A and B viruses. The approval was supported by results from randomized clinical trials. In individuals aged 50 to 64 years old, mFlusiva demonstrated higher efficacy compared with a standard-dose i

August is National Immunization Awareness Month (NIAM) in the United States. This yearly observance highlights the importance of vaccinations for everyone, including older adults. Since the COVID-19 pandemic, pharmacies have played an increasingly critical role in providing immunization services. We hope to continue supporting your efforts by highlighting available CDC resources, such as the Adult Immunization Schedule, tools like the PneumoRecs VaxAdvisor Mobile App to help

Medicare advertisement scams targeting older beneficiaries have surged on Facebook, with more than 200 million views recorded in 2025. Read the AOL report to learn about the different schemes these ads employ, such as fake Part D refund calls, AI voice-cloning scams, and fake Medicare card verification calls, and help educate your patients on how to recognize and avoid these scams.

Medicare is currently offering a temporary Bridge Program across all U.S. states and territories. Since July 1, 2026, eligible beneficiaries can now access certain GLP-1 weight-loss medications for $50 per month until December 31, 2027. Covered medications include: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only) To be eligible, beneficiaries must be enrolled in a Medicare prescription drug plan, including: Medicare Part D Medicare Advantage (Part C)

Some medications can interact with hot weather and increase the risk of heat‑related illness. This is especially concerning for older adults, who are more likely to take two or more of these medications at the same time. The CDC has described certain medications that can interact with heat and outlined ways clinicians can help. Some examples include: Diuretics (e.g., furosemide, hydrochlorothiazide) increase fluid loss and can lead to dehydration, electrolyte imbalances, an

As temperatures rise during the summer, older adults are at increased risk of dehydration, heat exhaustion, and heat stroke. Certain medications used to manage chronic conditions can further increase this risk. For example, diuretics increase fluid loss and may lead to dehydration. Older adults taking such medications may benefit from a medication review with their community pharmacist. Specifically, pharmacists can identify medications that may increase heat-related risks, p

Vaccination visits can sometimes be challenging for older adults. Factors such as unrecognized contraindications, anxiety related to needles, and concerns about pain may make the experience less comfortable and, in some cases, lead to dizziness or fainting. To help address these challenges, Immunize.org offers a collection of practical resources for healthcare providers. These short videos and tools highlight strategies to reduce pain and anxiety during vaccination (Video 1),

The CDC and state health departments continue to update the public on measles cases and outbreaks across the United States. According to CDC data , as of May 28, a total of 1,983 confirmed measles cases have been reported from 40 U.S. jurisdictions, including 9 cases among international visitors. Most cases occurred among children aged 5–19 years (51%), followed by adults aged 20 years or older (28%), and children under 5 years (21%). States such as South Carolina (669 cases)